First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/7332
PMID: 24946000
DOI: 10.1038/bjc.2014.346
ISSN: 0007-0920
Date issued
2014Journal title
BRITISH JOURNAL OF CANCER
Type of content
Artigo